Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above 200-Day Moving Average - What's Next?

Key Points

• Xtant Medical shares recently surpassed their 200-day moving average, trading at $0.63 compared to the average of $0.58.
• Institutional investors own 69.33% of Xtant Medical’s stock, with significant investments from firms like Nantahala Capital Management, which increased its stake by over 500%.
• The company focuses on regenerative medicine and medical devices for orthopedic and neurological surgeries, offering products like OsteoSponge and OsteoSelect DBM Putty.

Shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT - Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.58 and traded as high as $0.63. Xtant Medical shares last traded at $0.63, with a volume of 35,726 shares trading hands.

Xtant Medical Trading Down 1.6%

The company has a current ratio of 2.47, a quick ratio of 1.16 and a debt-to-equity ratio of 0.46. The company has a fifty day moving average price of $0.63 and a 200-day moving average price of $0.58. The firm has a market cap of $80.15 million, a price-to-earnings ratio of -15.38 and a beta of -0.15.

Hedge Funds Weigh In On Xtant Medical

Several large investors have recently bought and sold shares of XTNT. Jane Street Group LLC purchased a new position in shares of Xtant Medical during the second quarter worth about $26,000. Mink Brook Asset Management LLC boosted its position in Xtant Medical by 125.8% in the 2nd quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company's stock valued at $81,000 after buying an additional 60,997 shares during the last quarter. Crescent Grove Advisors LLC lifted its position in shares of Xtant Medical by 94.3% during the second quarter. Crescent Grove Advisors LLC now owns 412,024 shares of the medical device company's stock worth $304,000 after purchasing an additional 200,000 shares during the last quarter. AWM Investment Company Inc. acquired a new stake in Xtant Medical during the second quarter worth about $4,875,000. Finally, Nantahala Capital Management LLC increased its stake in shares of Xtant Medical by 500.3% in the second quarter. Nantahala Capital Management LLC now owns 68,394,000 shares of the medical device company's stock valued at $50,543,000 after purchasing an additional 57,000,000 shares during the period. Hedge funds and other institutional investors own 69.33% of the company's stock.

About Xtant Medical

Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.